[1] |
Teitelbaum I. Peritoneal dialysis [J]. N Engl J Med, 2021, 385(19): 1786-1795.
|
[2] |
Cho Y, Bello AK, Levin A, et al. Peritoneal dialysis use and practice patterns: an international survey study [J]. Am J Kidney Dis, 2021, 77(3): 315-325.
|
[3] |
Mehrotra R, Devuyst O, Davies SJ, et al. The current state of peritoneal dialysis [J]. J Am Soc Nephrol, 2016, 27(11): 3238-3252.
|
[4] |
Boudville N, Johnson DW, Zhao J. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study [J]. Nephrol Dial Transplant, 2019, 34(12): 2118-2126.
|
[5] |
Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center [J]. Ren Fail, 2021, 43(1): 993-1003.
|
[6] |
李洋,王亚芬,吴玉梅. 革兰阴性菌致腹膜透析相关性腹膜炎患者预后及危险因素[J]. 临床误诊误治,2019, 32(6): 76-80.
|
[7] |
Li P, Szeto C, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment [J]. Perit Dial Int, 2016, 36(5): 481-508.
|
[8] |
Perl J, Fuller DS, Boudville N, et al. Optimizing peritoneal dialysis-associated peritonitis prevention in the United States: from standardized peritoneal dialysis-associated peritonitis reporting and beyond [J]. Clin J Am Soc Nephrol, 2020, 16(1): 154-161.
|
[9] |
吴小漫,邓丽萍,麦美芳,等. 腹膜透析相关性腹膜炎患者病原菌及相关因素分析[J]. 中华医院感染学杂志,2018, 28(19): 2944-2947.
|
[10] |
Aldriwesh M, Alajroush L, Alangari R, et al. A retrospective analysis of peritoneal dialysis-associated peritonitis at a single-care children′s hospital in Saudi Arabia [J]. Saudi J Kidney Dis Transpl, 2021, 32(3): 735-743.
|
[11] |
Meng LF, Yang LM, Zhu XY, et al. Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: a multicenter retrospective cohort study [J]. World J Diabetes, 2020, 11(10): 435-446.
|
[12] |
李飞,陈文,李晓娃,等. 腹膜透析相关性腹膜炎病原菌分布及耐药性[J]. 中华医院感染学杂志,2020, 30(8): 1196-1200.
|
[13] |
Tan YL, Ooi GS, Vaithilingam I. Factors predicting clinical outcomes of continuous ambulatory peritoneal dialysis associated peritonitis - a single centre study [J]. Med J Malaysia, 2021, 76(3): 382-389.
|
[14] |
廖茂蕾,朱敏,王连梅,等. 单中心腹膜透析相关性腹膜炎常见病原菌及耐药性分析[J].华北理工大学学报(医学版), 2021, 23(6): 432-437.
|
[15] |
Chen H, Zhang F, Li R, et al. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota [J]. Biomed Pharmacother, 2020, 124: 109829.
|
[16] |
Jagirdar RM, Bozikas A, Zarogiannis SG, et al. Encapsulating peritoneal sclerosis: pathophysiology and current treatment options [J]. Int J Mol Sci, 2019, 20(22): 5765.
|
[17] |
Zhang D, Jiang L, Wang M, et al. Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration [J]. J Ethnopharmacol, 2021, 264: 113206.
|
[18] |
赵晶,杨立明,朱学研,等. 长腹膜透析龄患者首次腹膜炎的临床特征及治疗转归:基于4家医院625例患者数据[J]. 南方医科大学学报,2020, 40(12): 1740-1746.
|
[19] |
颜红,王春英,张蓓蕾,等. 动态监测血清CRP与PCT水平对预防急诊输液患者血流感染的意义[J]. 中华医院感染学杂志,2018, 28(1): 55-57.
|
[20] |
李茹. 降钙素原和C反应蛋白在血流感染菌属鉴别诊断中的应用价值[J]. 河南医学研究,2020, 29(12): 2259-2260.
|
[21] |
Yan ST, Sun LC, Jia HB, et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria [J]. Am J Emerg Med, 2017, 35(4): 579-583.
|
[22] |
Thomas-Rüddel DO, Poidinger B, Kott M, et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia [J]. Crit Care, 2018, 22(1): 128.
|
[23] |
Charles PE, Ladoire S, Aho S, et al.Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria [J].BMC Infect Dis, 2008, 8(1): 1-8.
|
[24] |
Niu D, Huang Q, Yang F, et al. Serum biomarkers to differentiate Gram-negative, Gram-positive and fungal infection in febrile patients [J]. J Med Microbiol, 2021, 70(7): doi: 10.1099/jmm.0.001360.
|
[25] |
蒋慧敏,王利,郭嘉,等. 血流感染脓毒症患者病原菌分布特点及炎症指标、凝血指标的监测分析[J]. 宁夏医学杂志,2022, 44(2): 129-132.
|
[26] |
Breijyeh Z, Jubeh B, Karaman R. Resistance of Gram-negative bacteria to current antibacterial agents and approaches to resolve it [J]. Molecules, 2020, 25(6): 1340.
|
[27] |
Gupta V, Datta P. Next-generation strategy for treating drug resistant bacteria: antibiotic hybrids [J]. Indian J Med Res, 2019, 149(2): 97-106.
|
[28] |
Exner M, Bhattacharya S, Christiansen B, et al. Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? [J]. GMS Hyg Infect Control, 2017, 12: Doc05.
|
[29] |
丁洁,李春庆,陈英兰,等. 腹膜透析相关性腹膜炎病原菌及其影响因素[J]. 中华医院感染学杂志,2020, 30(20): 3099-3103.
|
[30] |
Harmanjeet H, Jani H, Zaidi STR, et al. Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions [J]. Perit Dial Int, 2020, 40(5): 470-476.
|
[31] |
朱彦秋,陈瑾,尹丽娟,等. 腹膜透析相关性腹膜炎患者病原菌耐药性及预后分析[J]. 临床肾脏病杂志,2018, 18(2): 92-96.
|